Literature DB >> 8181844

Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.

W M Prodinger1, C Larcher, B M Sölder, D Geissler, M P Dierich.   

Abstract

Several European countries report a decreasing prevalence of antibodies to hepatitis A virus (anti-HAV). This trend is most pronounced in the youngest age groups. In 1979, however, 58% of young Austrians aged 20 to 30 years were shown to possess anti-HAV. Here we describe the current epidemiological situation in western Austria. Prevalence of anti-HAV has decreased to 7% in those 18 to 30 years old. This percentage rises to 20% (31 to 40 years of age) and 57% (41 to 50 years of age) and is highest in those older than 50 years (87%). Of 180 cases of clinical hepatitis A occurring from 1985 to 1992 45% were imported by travel to HAV-endemic areas. Seventy-one percent of the cases in children (59/83) occurred in foreign workers' families and were also predominantly acquired abroad. A change in prevention policy should be considered in this respect, as vaccination is available now.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181844     DOI: 10.1007/bf01780769

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Hepatitis A virus antibody in East Anglian blood donors.

Authors:  G Higgins; T G Wreghitt; J J Gray; J Blagdon; C E Taylor
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

2.  Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.

Authors:  R Vranckx; L Muylle
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

3.  Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.

Authors:  G Wiedermann; F Ambrosch; H Kollaritsch; H Hofmann; C Kunz; E D'Hondt; A Delem; F E André; A Safary; J Stéphenne
Journal:  Vaccine       Date:  1990-12       Impact factor: 3.641

Review 4.  Changing epidemiology and clinical aspects of hepatitis A.

Authors:  A Forbes; R Williams
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

5.  [The incidence of antibodies to hepatitis A virus in people from Vienna and certain Austrian provinces (author's transl)].

Authors:  W Frisch-Niggemeyer; C Kunz
Journal:  Wien Klin Wochenschr       Date:  1979-03-30       Impact factor: 1.704

6.  Antibody to hepatitis A virus in plasma of Danish blood donors and in immune serum globulin produced in Denmark.

Authors:  L R Mathiesen; P Skinhøj; F Balstrup
Journal:  Scand J Infect Dis       Date:  1980

7.  A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.

Authors:  A Werzberger; B Mensch; B Kuter; L Brown; J Lewis; R Sitrin; W Miller; D Shouval; B Wiens; G Calandra
Journal:  N Engl J Med       Date:  1992-08-13       Impact factor: 91.245

Review 8.  Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.

Authors:  P C Döller
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

9.  Hepatitis A in young Norwegian drug addicts and prison inmates.

Authors:  E Holter; J C Siebke
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

10.  Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.

Authors:  G G Frösner; G Papaevangelou; R Bütler; S Iwarson; A Lindholm; A Couroucé-Pauty; H Haas; F Deinhardt
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

View more
  5 in total

1.  Prevalence of hepatitis A, B and C in the Flemish population.

Authors:  M Beutels; P Van Damme; W Aelvoet; J Desmyter; F Dondeyne; C Goilav; R Mak; L Muylle; D Pierard; A Stroobant; F Van Loock; P Waumans; R Vranckx
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Authors:  Filippo Ansaldi; Bianca Bruzzone; Maria Cristina Rota; Antonino Bella; Marta Ciofi degli Atti; Paolo Durando; Roberto Gasparini; Giancarlo Icardi
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

3.  Prevalence of hepatitis C virus infection in Hashimoto's thyroiditis.

Authors:  B Wagner; H Vierhapper; H Hofmann
Journal:  BMJ       Date:  1996-03-09

4.  Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

Authors:  W Thierfelder; W Hellenbrand; H Meisel; E Schreier; R Dortschy
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 5.  Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.

Authors:  Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele
Journal:  BMC Infect Dis       Date:  2005-07-07       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.